Vincerx Pharma, Inc. Operating Cash Flow
Vincerx Pharma, Inc. reported Operating Cash Flow of -$4.45 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2025-05-15
- Vincerx Pharma, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-03-31 was -$4.45M.
- Vincerx Pharma, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-12-31 was -$6.18M.
- Vincerx Pharma, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-09-30 was -$6.38M.
- Vincerx Pharma, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-06-30 was -$5.83M.
- Vincerx Pharma, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$26.13M.
- Vincerx Pharma, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$40.45M.
- Vincerx Pharma, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$59.60M.
- Vincerx Pharma, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$33.40M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2025-03-31 | -$4.45M 10-Q · filed 2025-05-15 | -$10.63M derived: sum of 2 quarters · filed 2025-05-15 | -$17.01M derived: sum of 3 quarters · filed 2025-05-15 | -$22.84M derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | -$6.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$12.56M derived: sum of 2 quarters · filed 2025-03-27 | -$18.39M derived: sum of 3 quarters · filed 2025-03-27 | -$26.13M 10-K · filed 2025-03-27 |
| 2024-09-30 | -$6.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$12.21M derived: sum of 2 quarters · filed 2024-11-12 | -$19.95M 10-Q · filed 2024-11-12 | -$27.96M derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-06-30 | -$5.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$13.57M 10-Q · filed 2024-08-08 | -$21.59M derived: sum of 3 quarters · filed 2025-05-15 | -$28.23M derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-03-31 | -$7.74M 10-Q · filed 2025-05-15 | -$15.76M derived: sum of 2 quarters · filed 2025-05-15 | -$22.40M derived: sum of 3 quarters · filed 2025-05-15 | -$35.10M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$8.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$14.66M derived: sum of 2 quarters · filed 2025-03-27 | -$27.36M derived: sum of 3 quarters · filed 2025-03-27 | -$40.45M 10-K · filed 2025-03-27 |
| 2023-09-30 | -$6.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$19.34M derived: sum of 2 quarters · filed 2024-11-12 | -$32.43M 10-Q · filed 2024-11-12 | -$46.25M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$12.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$25.79M 10-Q · filed 2024-08-08 | -$39.61M derived: sum of 3 quarters · filed 2024-08-08 | -$54.48M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$13.09M 10-Q · filed 2024-05-14 | -$26.91M derived: sum of 2 quarters · filed 2024-05-14 | -$41.78M derived: sum of 3 quarters · filed 2024-05-14 | -$57.67M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$13.82M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$28.69M derived: sum of 2 quarters · filed 2024-03-29 | -$44.58M derived: sum of 3 quarters · filed 2024-03-29 | -$59.60M 10-K · filed 2024-03-29 |
| 2022-09-30 | -$14.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$30.76M derived: sum of 2 quarters · filed 2023-11-14 | -$45.79M 10-Q · filed 2023-11-14 | -$57.27M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$15.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$30.91M 10-Q · filed 2023-08-07 | -$42.40M derived: sum of 3 quarters · filed 2023-08-07 | -$52.70M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | -$15.03M 10-Q · filed 2023-05-11 | -$26.51M derived: sum of 2 quarters · filed 2023-05-11 | -$36.82M derived: sum of 3 quarters · filed 2023-05-11 | -$44.99M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$11.49M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$21.79M derived: sum of 2 quarters · filed 2023-03-28 | -$29.96M derived: sum of 3 quarters · filed 2023-03-28 | -$33.40M 10-K · filed 2023-03-28 |
| 2021-09-30 | -$10.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$18.48M derived: sum of 2 quarters · filed 2022-11-10 | -$21.92M 10-Q · filed 2022-11-10 | -$24.05M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$8.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$11.61M 10-Q · filed 2022-08-11 | -$13.75M derived: sum of 3 quarters · filed 2022-08-11 | -$13.87M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$3.44M 10-Q · filed 2022-05-12 | -$5.57M derived: sum of 2 quarters · filed 2022-05-12 | -$5.69M derived: sum of 3 quarters · filed 2022-05-12 | -$5.76M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$2.26M derived: sum of 2 quarters · filed 2022-03-29 | -$2.32M derived: sum of 3 quarters · filed 2022-03-29 | -$2.28M 10-K · filed 2022-03-29 |
| 2020-09-30 | -$121.92K 10-Q · filed 2020-11-10 | -$186.43K derived: sum of 2 quarters · filed 2020-11-10 | -$144.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | -$64.50K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-23 | -$165.33K 10-K · filed 2020-09-23 | ||
| 2020-03-31 | -$100.82K 10-Q · filed 2020-05-06 |